Cogstate (ASX:CGS) — Material Events
ASX:CGS · 9 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Cogstate’s FY25 Surge – Record Profits, Maiden Dividend, and AI on the HorizonMedium
Cogstate FY25 results show robust revenue and profit growth, maiden dividend declared, and strong FY26 outlook with AI launch
22 Aug 2025
·Investor Briefing
·85
Cogstate Surges with Record FY25 Results and AI-Driven Growth AheadMedium
Cogstate posts record FY25 results, declares maiden dividend, and outlines growth with AI launch and Medidata partnership
22 Aug 2025
·Annual Financial Results and Operational Update
·85
Cogstate’s Clinical Trial Sales More Than Double, Revenue Beats ForecastsMedium
Cogstate 1H26 sales contracts surge 105%, revenue beats guidance; earnings outlook improved
22 Jan 2026
·Business Update & Preliminary Results
·85
Cogstate Posts Record $89 Million Sales Contracts in FY26 with Strong FY27 BacklogMedium
Cogstate reports record $89 million FY26 sales contracts and strong FY27 revenue backlog
8 July 2026
·Business Update
·85
Cogstate Surges with 88% Jump in Sales Contracts, Eyes Growth in Psychiatry and AIMedium
Cogstate reports record sales growth and strong 1H26 outlook with ongoing growth investments
16 Oct 2025
·Business Update
·80
Cogstate Doubles Profit, Declares First Dividend Amid Revenue GrowthMedium
Cogstate FY25 revenue up 22%, profit before tax doubles, declares first dividend
22 Aug 2025
·Appendix 4E
·80
Cogstate Advances with 12% Revenue Growth and Expanding Clinical Trial ContractsMedium
Cogstate posts 12% revenue growth and 2% profit rise in H1 2026, boosts future clinical trial contracts
19 Feb 2026
·Appendix 4D and Half-Year Financial Report
·80
Cogstate’s Sales Contracts Surge Amid Revenue Timing ChallengesMedium
Cogstate reports strong sales contract growth but lowers 1H26 revenue and margin guidance due to timing delays and increased investments
10 Dec 2025
·Business Update
·75
Cogstate Reports Strong Q3 2026 Sales Contracts and Increased Revenue BacklogMedium
Cogstate Reports Strong Q3 2026 Sales Contracts and Increased Revenue Backlog
8 Apr 2026
·Business Update
·75
No articles in this tier for the last 12 months.
Market Mentions
4
- appeared in market wrap coverage
These are market wrap articles where Cogstate (ASX:CGS) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 28 (6 July -> 10 July) 2026
11 July 2026
Healthcare Wrap - Week 15 (6 Apr -> 10 Apr) 2026
11 Apr 2026
Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026
Healthcare Wrap - Week 4 (19 Jan -> 23 Jan) 2026
25 Jan 2026